Fig. 6

The function of EDV technology in lung cancer cells. EDV’s size is 400 ± 20 nanometers, and one EDV™ can be loaded with more than 1 million molecules of a cancer inhibitor medication. Significant concentrations of miRNAs, such as miR-16-5p mimics, are packed in empty EDVs. Then EDV™ is covered with a bispecific antibody. After this function, via the tumor microenvironment, the bispecific antibody attaches to the cancer cell membrane receptor. Afterward, the EDV™ has been absorbed, broken down inside the tumor cell, and set free miRNA. In doing this function, EDV™ Nano cells allow cancer therapies to be more powerful and tremendously less toxic